QT prolongation and torsades de pointes associated with clarithromycin

American Journal of Medicine

Volumn 104, Issue 4, 1998, Pages 395-396

  Lee, Kathy L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CLARITHROMYCIN; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ADULT; ARTICLE; BRONCHOPNEUMONIA; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; TORSADES DE POINTES;

EID: 0031944690     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00059-X     Document Type: Article

References (2)

1. McComb JM, Campbell MPS, Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cordial. 1984;54:992-993.
2. Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF. Association of intravenous erythromycin and potentially fatal ventricular tachycardia with QT prolongation (torsades de pointes). BMJ. 1990;300: 1375-1376.